Cargando…
Ten-year outcome of anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration
PURPOSE: The aim of this study was to report the 10-year visual outcome in eyes treated with anti-vascular endothelial growth factor (anti-VEGF) agents for neovascular age-related macular degeneration (nAMD) and to assess the impact of switching treatment as part of routine clinical care. METHODS: E...
Autores principales: | Upasani, Deepa, Dhingra, Narendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8544087/ https://www.ncbi.nlm.nih.gov/pubmed/34427220 http://dx.doi.org/10.4103/ijo.IJO_2868_20 |
Ejemplares similares
-
Patterns of treatment discontinuation in patients receiving anti-vascular endothelial growth factor for neovascular age-related macular degeneration
por: Dhingra, Narendra, et al.
Publicado: (2022) -
Ten-Year Real-World Outcomes of Anti-Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration
por: Cheema, Muhammad Raza, et al.
Publicado: (2021) -
Ten-year outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration
por: Chandra, Shruti, et al.
Publicado: (2020) -
Twenty Years of Anti-Vascular Endothelial Growth Factor Therapeutics in Neovascular Age-Related Macular Degeneration Treatment
por: Moon, Bo-Hyun, et al.
Publicado: (2023) -
Outcome of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration in real-life setting
por: Kataja, Maria, et al.
Publicado: (2018)